FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

785638005: Product containing only betamethasone and neomycin in otic dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3767790013 Betamethasone and neomycin only product in otic dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3767791012 Product containing only betamethasone and neomycin in otic dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betamethasone and neomycin only product in otic dose form Count of base of active ingredient deux false Inferred relationship Some
Betamethasone and neomycin only product in otic dose form est un(e) (attribut) Betamethasone and neomycin only product true Inferred relationship Some
Betamethasone and neomycin only product in otic dose form est un(e) (attribut) Betamethasone- and neomycin-containing product in otic dose form true Inferred relationship Some
Betamethasone and neomycin only product in otic dose form a une forme pharmaceutique (attribut) forme pharmaceutique pour usage auriculaire (forme pharmaceutique) true Inferred relationship Some
Betamethasone and neomycin only product in otic dose form a pour principe actif (attribut) Betamethasone true Inferred relationship Some 1
Betamethasone and neomycin only product in otic dose form a pour principe actif (attribut) Neomycin (substance) true Inferred relationship Some 2
Betamethasone and neomycin only product in otic dose form Plays role Antibacterial therapeutic role (role) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear or eye or nose drops (clinical drug) est un(e) (attribut) True Betamethasone and neomycin only product in otic dose form Inferred relationship Some

This concept is not in any reference sets

Back to Start